Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH reports net income of $2.68 million in H1 2018

2018-09-04

According to the financial statements of Jerusalem Pharmaceuticals JPH for the first half of 2018, Net profit after tax of the period reached 2,680,539 USD Compared with Net profit after tax 3,026,907 USD for 2017, a net decrease in profit of 11.44%.Total assets of the company reached 60,282,882 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net decrease of 2.18%.Total liabilities of the company reached 13,001,634 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net increase of 6.24%. Net ownership equity of the company reached 47,281,248 USD (Including Non-Controlling Interests of 815,902 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net decrease of 4.27%.

 


 

2021-04-08
QUDS approves distributing 3.50% stocks dividends and 4.50% cash dividends for the year 2020

2021-04-08
TRUST approves distributing 10% cash dividends for the year 2020

2021-04-08
Relative Calmness in the PEX and a momentum in holding the general assembly meetings

2021-04-08
NCI proposes distributing 10% cash dividends for the year 2020

2021-04-08
PEC approves distributing 10% cash dividends for the year 2020

2021-04-04
NIC approves distributing 15% stocks dividends and 22.5% cash dividends for the year 2020

2021-04-01
APIC proposes distributing 9.1476% stocks dividends and 7.50% cash dividends for the year 2020

2021-04-01
Al-Quds Index declines significantly following the dividends’ entitlement of the PEX’s two largest companies

2021-04-01
BOP approves distributing 1% stocks dividends and 4% cash dividends for the year 2020

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013